Login/Sign Up

MRP ₹61541
(Inclusive of all Taxes)
₹7384.9 Cashback (12%)
Biomab Egfr 50 mg Injection is used to treat head and neck cancer. It contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer. Nimotuzumab may also be indicated in treating glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
Provide Delivery Location
About Biomab Egfr 50 mg Injection
Biomab Egfr 50 mg Injection belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. It may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
Biomab Egfr 50 mg Injection contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.
In some cases, Biomab Egfr 50 mg Injection may cause side effects like fever, chills, headache, itching, and mucositis. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
Do not use Biomab Egfr 50 mg Injection if you are allergic to any of its components. Consult the doctor if you are pregnant or breastfeeding. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.
Uses of Biomab Egfr 50 mg Injection
Biomab Egfr 50 mg Injection is used in the treatment of Head and neck cancer. The detailed use of Biomab Egfr 50 mg Injection is as follows:

Have a query?
Directions for Use
Medicinal Benefits
Biomab Egfr 50 mg Injection belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. Biomab Egfr 50 mg Injection contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer. Nimotuzumab may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
How Biomab Egfr 50 mg Injection Works
Storage
What if I have taken an overdose of Biomab Egfr 50 mg Injection
Drug Warnings
Do not use Biomab Egfr 50 mg Injection if you are allergic to any of its components. Inform the doctor if you are pregnant or breastfeeding. Please consult the doctor if you have any concerns regarding the usage of Biomab Egfr 50 mg Injection in children. Let the doctor know if you have any health conditions or if you are taking any medications, including herbal supplements.
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Consult your doctor
It is not known if alcohol affects Biomab Egfr 50 mg Injection. Please consult the doctor.
Pregnancy
Caution
Consult the doctor if you are pregnant. It should be used during pregnancy only if the benefits outweigh the risks.
Breast Feeding
Caution
It is not known if this medicine passes into breast milk. Consult the doctor if you are breastfeeding.
Driving
Consult your doctor
It is unknown if Biomab Egfr 50 mg Injection affects your ability to drive. Drive only if you are alert.
Liver
Consult your doctor
If you have a history of liver problems, inform the doctor before receiving Biomab Egfr 50 mg Injection.
Kidney
Consult your doctor
If you have a history of kidney problems, inform the doctor before receiving Biomab Egfr 50 mg Injection.
Children
Caution
Please consult the doctor if you have any concerns regarding the usage of Biomab Egfr 50 mg Injection in children.
Heart
Please consult your doctor before receiving Biomab Egfr 50 mg Injection if you have pre-existing heart problems. Your doctor will prescribe Biomab Egfr 50 mg Injection if the benefits outweigh the risks.
Geriatrics
Safe if prescribed
Biomab Egfr 50 mg Injection is generally considered safe when used under medical supervision in geriatric patients. However, please consult your doctor if you have any concerns.
Biomab Egfr 50 mg Injection is used to treat Head and neck cancer.
Biomab Egfr 50 mg Injection works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.
Biomab Egfr 50 mg Injection may cause hypertension (high blood pressure) and fluctuation in blood pressure. Consult the doctor if you have high blood pressure or if you experience fluctuation in blood pressure.
Mucositis (swelling and irritation of mucosa) could be a side effect of Biomab Egfr 50 mg Injection. If the condition persists or worsens, consult the doctor.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Cipla Ltd
Adley Formulations
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Admac Lifesciences(Oncology)
Halsted Pharma Pvt Ltd
Glenmark Pharmaceuticals Ltd
Neon Laboratories Ltd
United Biotech Pvt Ltd
Alkem Laboratories Ltd
Samarth Life Sciences Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Emcure Pharmaceuticals Ltd
Axiommax Oncology Pvt Ltd
GLS Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
Hetero Healthcare Pvt Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Novartis India Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Aureate Healthcare
Biochem Pharmaceutical Industries Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Delarc Pharmaceuticals Pvt Ltd
Zee Laboratories Ltd
Amps Biotech Biotech Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Aimcad Biotech Pvt Ltd
Getwell Oncology Pvt Ltd
Msn Laboratories Pvt Ltd
Reliance Formulation Pvt Ltd
Allieva Pharma Pvt Ltd
Astra Zeneca Pharma India Ltd
Lucien Life Sciences
Getwell Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Del Trade International Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
Cadila Pharmaceuticals Ltd
Dabur India Ltd
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Symbion Lifescience
Vhb Life Sciences Inc
Zuvius Lifesciences Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Bruck Pharma Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Adley Oncology
Admac Pharma Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Reliance Life Sciences Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Zuventus Healthcare Ltd
Astellas Pharma India Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Mankind Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley & Bdl
Aprazer Healthcare Pvt Ltd
Aureate Pharma
Caitlin Life Care
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd